AMT-562 in Patients With Selected Advanced Solid Tumors

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 20, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Advanced Solid Tumors

Interventions

DRUG

AMT-562

Administered AMT-562 for injection intravenously

Trial Locations (2)

RECRUITING

Macquarie University Hospital, North Ryde

RECRUITING

Cabrini Malvern Hospital, Malvern

All Listed Sponsors

lead

Multitude Therapeutics (Australia) Pty Ltd

INDUSTRY